Replies to post #542109 on NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

Having put a spotlight on the specific trading tactics alleged to be spoofing, it would be beyond brazen and dismissive of the law for a MM to continue the practice, especially on good news.

Justice presumably would particularly punish such continued offenses by the same alleged parties, or you’d hope so.

The spoofing pattern sounds like it would be easy to write code that detects new occurrences in near real time and log and issue alerts, imo.

[Maverick0408]

I, for one, would like other promising biotechs to join this movement. These crooks would continue manipulating other upcoming biotechs and thereby preventing/delaying important advances that improves patients lives. They ought to be punished!

Kudos to LP and the management for a well planned strategy! It’s also amazing how the top neurosurgery departments around the world are supporting our therapy and excellent data in unison.

[pqr]

PM: interesting question. IMO putting out an attack article behind a paywall is something that would be done on advice of the journalist’s counsel. Conversely it seems highly unlikely that management would be satisfied with this as a compromise. Or, candidly, that the parties you mention would communicate at all other than perhaps (and I have NO specific information to support this) the company sending a journalist or publisher a cease and desist letter putting those potential adversaries on formal notice. That is what I would have done months ago because it would help to establish an element of a potential slander claim, knowledge of falsity. Very high NYT v Sullivan standard of course.